AVTR — Avantor Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Avantor, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	6,040	6,394	7,386	7,512	6,967
Cost of Revenue
Gross Profit	1,921	2,081	2,503	2,603	2,364
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	5,562	6,034	6,426	6,395	6,278
Operating Profit	478	360	960	1,118	690
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	40.6	62.3	753	851	411
Provision for Income Taxes
Net Income After Taxes	37.8	117	573	687	321
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	37.8	117	573	687	321
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-335	52	508	662	321
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.513	0.5	0.989	1.02	0.714